Fentanyl patch - Kyukyu Pharmaceutical/Maruishi Pharmaceutical

Drug Profile

Fentanyl patch - Kyukyu Pharmaceutical/Maruishi Pharmaceutical

Alternative Names: Fentanyl film - Nippon Kayaku; MRQ-01; NKQ-01

Latest Information Update: 18 Apr 2017

Price : $50

At a glance

  • Originator Kyukyu Pharmaceutical
  • Developer Maruishi Pharmaceutical
  • Class General anaesthetics; Opioid analgesics; Piperidines; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Cancer pain

Most Recent Events

  • 31 Mar 2017 Maruishi Pharmaceutical completes a phase III trial in Cancer pain in Japan (Transmucosal) (JapicCTI-152916)
  • 31 Mar 2017 Maruishi Pharmaceutical completes a long-term phase III trial for Cancer pain in Japan (Transmucosal) (JapicCTI-152909)
  • 08 Aug 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top